Cargando…

Role of Ovarian Function Suppression in Premenopausal Women with Early Breast Cancer

Historically, endocrine therapy for breast cancer began with ovarian ablation (OA) for the treatment of premenopausal patients. After the identification of estrogen receptors and the development of many antiestrogens, tamoxifen has been approved and used as the standard endocrine therapy for hormona...

Descripción completa

Detalles Bibliográficos
Autor principal:	Park, Woo-Chan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204040/ https://www.ncbi.nlm.nih.gov/pubmed/28053622 http://dx.doi.org/10.4048/jbc.2016.19.4.341

Ejemplares similares

Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer
por: Xue, Cong, et al.
Publicado: (2016)

Ovarian reserve in premenopausal women with breast cancer
por: Zong, Xiangyun, et al.
Publicado: (2022)

Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor
por: Jordan, Jennifer H, et al.
Publicado: (2021)

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
por: Lu, Yen-Shen, et al.
Publicado: (2021)

Goserelin Ovarian Ablation Failure in Premenopausal Women With Breast Cancer
por: Gupta, Aanchal, et al.
Publicado: (2021)

Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer
por: Venturelli, Marta, et al.
Publicado: (2018)

Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer
por: Qiu, Lin, et al.
Publicado: (2016)

Contraceptive Use in Premenopausal Women With Early Breast Cancer
por: Lambertini, Matteo, et al.
Publicado: (2022)

Effects of soy foods on ovarian function in premenopausal women
por: Wu, A H, et al.
Publicado: (2000)

Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer
por: Anderson, Richard A., et al.
Publicado: (2022)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer
por: Blondeaux, Eva, et al.
Publicado: (2021)

Birth characteristics of premenopausal women with breast cancer.
por: Le Marchand, L., et al.
Publicado: (1988)

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer
por: Hackshaw, Allan, et al.
Publicado: (2009)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
por: Aft, Rebecca
Publicado: (2012)

Adjuvant ovarian suppression for premenopausal hormone receptor-positive breast cancer: A network meta-analysis
por: Jiang, Mengjie, et al.
Publicado: (2021)

Ovarian preservation for premenopausal women with early-stage endometrial cancer: a Chinese retrospective study
por: Lyu, Tianjiao, et al.
Publicado: (2019)

Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women
por: Yamazaki, Rena, et al.
Publicado: (2015)

Inclusion of premenopausal women in breast cancer clinical trials
por: Corrigan, Kelsey L., et al.
Publicado: (2022)

Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study
por: Iversen, A., et al.
Publicado: (2011)

Physical activity and risk of breast cancer in premenopausal women
por: Colditz, G A, et al.
Publicado: (2003)

Adjuvant hormonal therapy in premenopausal women with breast cancer
por: Smyth, Lillian, et al.
Publicado: (2015)

Genomic signature of parity in the breast of premenopausal women
por: Santucci-Pereira, Julia, et al.
Publicado: (2019)

Ovarian Inguinal Hernia in Premenopausal Women: A Case Report
por: Samantroy, Subhra, et al.
Publicado: (2021)

Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women
por: Han, Yunan, et al.
Publicado: (2022)

Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer.
por: Bianco, A. R., et al.
Publicado: (1991)

Lipidome of mammographic breast density in premenopausal women
por: Getz, Kayla R., et al.
Publicado: (2023)

Selective estrogen receptor modulators in the prevention of breast cancer in premenopausal women: a review
por: Oceguera-Basurto, Paola, et al.
Publicado: (2020)

Ovarian function and ovarian blood supply following premenopausal abdominal hysterectomy
por: Abdelazim, Ibrahim A., et al.
Publicado: (2015)

Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer
por: Parisi, Francesca, et al.
Publicado: (2020)

Study of the availability of digital mammography for premenopausal women in the Valencian Breast Cancer Early Detection Program
por: Ramos, M, et al.
Publicado: (2008)

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
por: Lambertini, Matteo, et al.
Publicado: (2019)

Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study
por: Ozaki, Yukinori, et al.
Publicado: (2018)

Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma
por: Nasioudis, Dimitrios, et al.
Publicado: (2017)

Postoperative outcomes of ovarian preserving surgery in premenopausal women with adnexal torsion
por: Choi, Euna, et al.
Publicado: (2023)

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
Publicado: (2022)

The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress
por: Kim, Hyun-Ah, et al.
Publicado: (2016)

Coffee, Tea, and Mammographic Breast Density in Premenopausal Women
por: Odama, Adashi Margaret, et al.
Publicado: (2021)

Adjuvant ovarian function suppression and cognitive function in women with breast cancer
por: Phillips, Kelly-Anne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_37caerbcuon2mivav810cl4ccq